apomorphine has been researched along with substance p in 27 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 17 (62.96) | 18.7374 |
| 1990's | 5 (18.52) | 18.2507 |
| 2000's | 4 (14.81) | 29.6817 |
| 2010's | 1 (3.70) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Carlsson, A | 1 |
| Cohn, M; Cohn, ML | 1 |
| Rinne, UK | 1 |
| Barbeau, A; Belanger, F; Jolicoeur, FB; Rondeau, DB | 2 |
| Grimes, L; Hong, JS; Iadarola, MJ; Merchenthaler, IJ; Pennypacker, KR; Ye, H; Zhang, WQ | 1 |
| Bennett, JP; Orosz, D | 1 |
| Brodin, E; Goiny, M; Lagercrantz, H; Pantaleo, T; Runold, M; Srinivasan, M; Yamamoto, Y | 1 |
| Battistella, A; Boarato, E; Bruni, A; Mietto, L; Palatini, P; Toffano, G | 1 |
| Hong, JS; Huang, YS; Li, SJ; McGinty, JF; Sivam, SP | 1 |
| Feldman, M; O'Dorisio, TM; Samson, WK | 1 |
| Gunne, LM; Häggström, JE; Johansson, P; Levin, ED; Terenius, L | 1 |
| Sundén-Kuronen, B | 1 |
| Barbeau, A; Butterworth, RF; DeMichele, G; Jolicoeur, FB; Rondeau, DB | 1 |
| Crossman, AR; Lee, LA; Slater, P | 1 |
| Alphs, L; Hanson, G; Lovenberg, W; Pradhan, S | 1 |
| Janicki, P; Libich, J; Lypko, A; Szczudlik, A | 1 |
| Kato, T; Koshiya, K | 1 |
| Chubb, IW; Greenfield, SA; Grünewald, RA; Henderson, Z; May, J; Portnoy, S; Weston, J; Wright, MC | 1 |
| Gibb, JW; Hanson, GR; Sonsalla, PK | 1 |
| Chesselet, MF; Ciaramitaro, VM; Delfs, JM; Parry, TJ | 1 |
| Granata, R; Jenner, P; Jolkkonen, J; Marsden, CD | 1 |
| Hikida, T; Ichinose, H; Kaneko, S; Kreitman, RJ; Nagatsu, T; Nakanishi, S; Pastan, I; Watanabe, D | 1 |
| Baláspiri, L; Gálfi, M; László, F; László, FA; Morschl, E; Pávó, I; Tóth, R; Varga, C | 1 |
| Jia, J; Li, B; Liu, L; Pan, Y; Sun, Z; Wang, H; Wang, X; Yu, F; Zhang, L | 1 |
| Gao, DM; Jiao, JJ; Zhuang, XY | 1 |
| Chan, YS; Chen, LW; Chu, JM; Yung, KK | 1 |
2 review(s) available for apomorphine and substance p
| Article | Year |
|---|---|
Recent advances in research on Parkinsonism.
Topics: Acetylcholinesterase; Adult; Apomorphine; Benserazide; Brain; Bromocriptine; Carbidopa; Dopa Decarboxylase; Dopamine; Drug Therapy, Combination; gamma-Aminobutyric Acid; Humans; Levodopa; Norepinephrine; Parkinson Disease; Selegiline; Serotonin; Substance P; Tyrosine 3-Monooxygenase | 1978 |
Neurobiochemical changes in tardive dyskinesia.
Topics: Animals; Antipsychotic Agents; Apomorphine; Cebus; Dyskinesia, Drug-Induced; gamma-Aminobutyric Acid; Rats; Substance P; Substantia Nigra | 1988 |
25 other study(ies) available for apomorphine and substance p
| Article | Year |
|---|---|
Some aspects of dopamine in the basal ganglia.
Topics: Age Factors; Animals; Apomorphine; Basal Ganglia; Carboxy-Lyases; Dopamine; Dose-Response Relationship, Drug; Feedback; gamma-Aminobutyric Acid; Humans; Rats; Receptors, Dopamine; Substance P; Tyrosine 3-Monooxygenase | 1976 |
Comparison of the regulation of rotational behavior by hypothalamic oligopeptides.
Topics: Animals; Apomorphine; Behavior, Animal; Glutathione; Gonadotropin-Releasing Hormone; Humans; Hypothalamus; Motor Activity; MSH Release-Inhibiting Hormone; Pituitary Hormone Release Inhibiting Hormones; Pituitary Hormone-Releasing Hormones; Rats; Reserpine; Stereotyped Behavior; Substance P | 1977 |
Effect of brain peptides on hypokinesia produced by anterolateral hypothalamic 6-OHDA lesions in rats.
Topics: Animals; Apomorphine; Humans; Hydroxydopamines; Hypothalamus; Male; Motor Activity; Rats; Somatostatin; Stereotyped Behavior; Substance P; Thyrotropin-Releasing Hormone | 1979 |
Motor activity induced by substance P in rats.
Topics: Animals; Apomorphine; Dextroamphetamine; Drug Interactions; Humans; Male; Motor Activity; Rats; Stereotyped Behavior; Substance P; Time Factors | 1978 |
A 35 kDa Fos-related antigen is co-localized with substance P and dynorphin in striatal neurons.
Topics: Animals; Apomorphine; Blotting, Western; Corpus Striatum; Dopamine; Dynorphins; Genes, fos; Immunohistochemistry; Male; Molecular Weight; Neurons; Proto-Oncogene Proteins c-fos; Rats; Rats, Inbred Strains; Substance P; Substantia Nigra | 1992 |
Baseline and apomorphine-induced extracellular levels of nigral substance P are increased in an animal model of Parkinson's disease.
Topics: Animals; Apomorphine; Dialysis; Disease Models, Animal; Dopamine; Ganglia, Sympathetic; Hydroxydopamines; Neurons; Oxidopamine; Parkinson Disease, Secondary; Rats; Rats, Inbred Strains; Substance P; Substantia Nigra | 1990 |
Enhanced in vivo release of substance P in the nucleus tractus solitarii during hypoxia in the rabbit: role of peripheral input.
Topics: Animals; Apomorphine; Carotid Sinus; Chemoreceptor Cells; Dialysis; Dopamine; Hypoxia; Medulla Oblongata; Neurons, Afferent; Peripheral Nerves; Phrenic Nerve; Rabbits; Radioimmunoassay; Substance P | 1991 |
Apomorphine-induced inhibition of histamine release in rat peritoneal mast cells.
Topics: Adenosine Triphosphate; Animals; Apomorphine; Histamine Release; In Vitro Techniques; Lysophospholipids; Male; Mast Cells; p-Methoxy-N-methylphenethylamine; Peritoneal Cavity; Phosphatidylserines; Rats; Rats, Inbred Strains; Substance P; Tetradecanoylphorbol Acetate | 1986 |
Dopaminergic regulation of tachykinin metabolism in the striatonigral pathway.
Topics: Animals; Apomorphine; Brain Chemistry; Corpus Striatum; Dextroamphetamine; Dose-Response Relationship, Drug; Haloperidol; Male; Neurokinin A; Neuropeptides; Protein Precursors; Rats; Rats, Inbred F344; Receptors, Dopamine; RNA, Messenger; Substance P; Substantia Nigra; Tachykinins | 1987 |
Apomorphine-induced nausea in humans: release of vasopressin and pancreatic polypeptide.
Topics: Adult; Apomorphine; Female; Humans; Infusions, Intravenous; Nausea; Oxytocin; Pancreatic Polypeptide; Substance P; Vasoactive Intestinal Peptide; Vasopressins | 1988 |
Experimental dyskinesias of the jaw: central and oral induction of the periodontal-masseteric reflex in the rat.
Topics: Animals; Antipsychotic Agents; Apomorphine; Bruxism; Hypnotics and Sedatives; Male; Masticatory Muscles; Movement Disorders; Muscle Relaxants, Central; Muscle Tonus; Nerve Degeneration; Periodontium; Rats; Rats, Inbred Strains; Receptors, Dopamine; Reflex; Sensation; Serotonin; Substance P | 1984 |
Effects of glutamate and aspartate on ataxic gait induced by 3-acetyl pyridine in rats.
Topics: Amphetamine; Animals; Apomorphine; Aspartic Acid; Ataxia; Gait; Glutamates; Male; Pyridines; Rats; Substance P; Thyrotropin-Releasing Hormone | 1980 |
The role of the substantia nigra in a striatally-evoked motor response in the rat: effects of intranigral drugs and lesions.
Topics: Animals; Apomorphine; Atropine; Corpus Striatum; Electric Stimulation; Enkephalins; Female; Functional Laterality; gamma-Aminobutyric Acid; Kainic Acid; Mesencephalon; Movement; Nicotine; Pyrrolidines; Rats; Strychnine; Substance P; Substantia Nigra | 1981 |
Response of striatonigral substance P systems to a dopamine receptor agonist and antagonist.
Topics: Animals; Apomorphine; Corpus Striatum; Haloperidol; Male; Rats; Receptors, Dopamine; Substance P; Substantia Nigra | 1981 |
Substance P levels in the rat forebrain after apomorphine and haloperidol treatment.
Topics: Animals; Apomorphine; Brain; Haloperidol; Male; Rats; Receptors, Dopamine; Substance P | 1981 |
Acute changes in nigral substance P content induced by drugs acting on dopamine, muscarine and GABA receptors.
Topics: Animals; Apomorphine; Haloperidol; Male; Oxotremorine; Picrotoxin; Rats; Receptors, Cell Surface; Receptors, Dopamine; Receptors, GABA-A; Receptors, Muscarinic; Substance P; Substantia Nigra | 1983 |
A non-cholinergic function for acetylcholinesterase in the substantia nigra: behavioural evidence.
Topics: Acetylcholine; Acetylcholinesterase; Animals; Apomorphine; Behavior, Animal; Dopamine; Male; Rats; Receptors, Dopamine; Substance P; Substantia Nigra | 1984 |
Opposite responses in the striato-nigral substance P system to D1 and D2 receptor activation.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Apomorphine; Appetite Depressants; Benzazepines; Corpus Striatum; Male; Methamphetamine; Phenethylamines; Rats; Rats, Inbred Strains; Receptors, Dopamine; Receptors, Dopamine D1; Receptors, Dopamine D2; Substance P; Substantia Nigra | 1984 |
Subthalamic nucleus lesions: widespread effects on changes in gene expression induced by nigrostriatal dopamine depletion in rats.
Topics: Animals; Apomorphine; Behavior, Animal; Corpus Striatum; Dopamine; Enkephalins; Gene Expression Regulation; Globus Pallidus; Glutamate Decarboxylase; Male; Oxidopamine; Rats; Rats, Sprague-Dawley; RNA, Messenger; Somatostatin; Stereotyped Behavior; Substance P; Substantia Nigra; Thalamic Nuclei | 1995 |
Acute and subchronic effects of dopamine agonists on neuropeptide gene expression in the rat striatum.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Apomorphine; Dopamine Agonists; Enkephalins; Ergolines; Gene Expression; In Situ Hybridization; Male; Neostriatum; Pergolide; Quinpirole; Rats; Rats, Wistar; Receptors, Dopamine D1; Receptors, Dopamine D2; RNA, Messenger; Substance P | 1995 |
Synaptic integration mediated by striatal cholinergic interneurons in basal ganglia function.
Topics: Acetylcholine; Animals; Apomorphine; Basal Ganglia; Choline O-Acetyltransferase; Corpus Striatum; Dopamine; Dopamine Agonists; Down-Regulation; Enkephalins; Immunotoxins; Interneurons; Mice; Mice, Transgenic; Motor Activity; Oxidopamine; Posture; Receptors, Dopamine D1; Receptors, Dopamine D2; Receptors, Glutamate; Substance P; Synapses | 2000 |
Inhibitory effect of galanin on dopamine-induced enhanced vasopressin secretion in rat neurohypophyseal tissue cultures.
Topics: Animals; Apomorphine; Culture Techniques; Dopamine; Dopamine Agonists; Dopamine Antagonists; Dose-Response Relationship, Drug; Drug Interactions; Galanin; Hypothalamus; Kinetics; Male; Pituitary Gland, Posterior; Radioimmunoassay; Rats; Rats, Wistar; Receptors, Neuropeptide; Substance P; Vasopressins | 2002 |
Electro-acupuncture stimulation improves motor disorders in Parkinsonian rats.
Topics: Animals; Antiparkinson Agents; Apomorphine; Brain; Disease Models, Animal; Dopamine; Dyskinesias; Electroacupuncture; Enkephalins; Glutamate Decarboxylase; Male; Medial Forebrain Bundle; Motor Activity; Neurons; Parkinsonian Disorders; Random Allocation; Rats; Rats, Wistar; RNA, Messenger; Substance P; Tyrosine 3-Monooxygenase | 2009 |
[The effects of intranigral microinjection of substance P on apomorphine-induced rotational behavior in 6-OHDA lesions rats].
Topics: Animals; Apomorphine; Behavior, Animal; Dyskinesia, Drug-Induced; Male; Motor Activity; Rats; Rats, Sprague-Dawley; Rotation; Substance P; Substantia Nigra | 2001 |
Neuroprotective effects of neurokinin receptor one in dopaminergic neurons are mediated through Akt/PKB cell signaling pathway.
Topics: Analysis of Variance; Animals; Apomorphine; bcl-Associated Death Protein; Caspase 3; Cell Death; Cell Line, Tumor; Corpus Striatum; Disease Models, Animal; Dopamine Agonists; Dopaminergic Neurons; Dose-Response Relationship, Drug; Drug Interactions; Enzyme Inhibitors; Gene Expression Regulation; L-Lactate Dehydrogenase; Male; Motor Activity; Neuroblastoma; Neurokinin-1 Receptor Antagonists; Neuroprotective Agents; Neurotoxicity Syndromes; Oxidopamine; Peptide Fragments; Proto-Oncogene Proteins c-akt; Pyrrolidonecarboxylic Acid; Rats; Rats, Sprague-Dawley; Receptors, Neurokinin-1; Rotarod Performance Test; Signal Transduction; Substance P; Sympatholytics; Time Factors; Tyrosine 3-Monooxygenase | 2011 |